iRhythm Technologies Target Price

Where could IRTC trade next? Consensus target price: $170.

Get informed when a big investor buys or sells

+ Follow

Share Price

$123.07

Average Target Price

$167.60

36.2% upside

10 analysts in the last 4 months

High: $196 | Low: $150

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-18	Wells Fargo	$168	36.5% upside
2026-08-10	Truist Financial	$168	36.5% upside
2026-08-07	Evercore ISIVijay Kumar	$165	34.1% upside
2026-08-07	Robert W. Baird	$165	34.1% upside
2026-08-07	Canaccord Genuity	$196	59.3% upside
2026-08-07	NeedhamDavid Saxon	$192	56% upside
2026-07-22	Stephens	$160	30% upside
2026-07-16	Truist FinancialRichard Newitter	$160	30% upside
2026-07-06	Evercore ISIVijay Kumar	$150	21.9% upside
2026-06-01	Canaccord GenuityWilliam Plovanic	$152	23.5% upside
2026-05-01	Truist Financial	$174	41.4% upside
2026-05-01	Robert W. Baird	$175	42.2% upside
2026-05-01	Evercore ISI	$160	30% upside
2026-05-01	Oppenheimer	$185	50.3% upside
2026-05-01	Needham	$255	107.2% upside
2026-05-01	Canaccord Genuity	$180	46.3% upside
2026-04-15	Truist FinancialRichard Newitter	$170	38.1% upside
2026-02-23	Goldman Sachs	$184	49.5% upside
2026-02-20	Truist FinancialRichard Newitter	$200	62.5% upside
2026-02-20	Robert W. Baird	$200	62.5% upside
2026-01-13	Wells Fargo	$225	82.8% upside
2026-01-09	Goldman Sachs	$211	71.4% upside
2026-01-05	Evercore ISIVijay Kumar	$210	70.6% upside
2025-12-18	Truist Financial	$215	74.7% upside
2025-12-02	Morgan Stanley	$205	66.6% upside
2025-10-31	Goldman SachsDavid Roman	$202	64.1% upside
2025-10-31	Oppenheimer	$225	82.8% upside
2025-10-31	Robert W. BairdDavid Rescott	$235	90.9% upside
2025-10-31	Loop Capital MarketsGene Mannheimer	$220	78.8% upside
2025-10-31	Canaccord Genuity	$212	72.3% upside
2025-10-31	NeedhamDavid Saxon	$244	98.3% upside
2025-10-15	Truist FinancialRichard Newitter	$205	66.6% upside
2025-10-13	UBS	$195	58.4% upside
2025-10-10	Robert W. BairdDavid Rescott	$220	78.8% upside
2025-09-29	Canaccord Genuity	$193	56.8% upside
2025-08-28	NeedhamDavid Saxon	$193	56.8% upside
2025-07-14	BTIGMarie Thibault	$165	34.1% upside
2025-05-05	Truist FinancialRichard Newitter	$146	18.6% upside
2025-01-08	OppenheimerSuraj Kalia	$120	2.5% downside
2024-10-31	NeedhamMichael Matson	$96	22% downside
2024-10-22	Truist FinancialDavid Rescott	$95	22.8% downside
2024-10-15	Robert W. BairdDavid Rescott	$100	18.7% downside
2024-10-14	Truist FinancialRichard Newitter	$80	35% downside
2024-10-04	Goldman SachsDavid Roman	$78	36.6% downside
2024-09-25	Canaccord GenuityWilliam Plovanic	$137	11.3% upside
2024-08-02	Truist FinancialRichard Newitter	$117	4.9% downside
2024-08-02	OppenheimerSuraj Kalia	$145	17.8% upside
2024-08-02	BTIGMarie Thibault	$125	1.6% upside
2024-07-16	Truist FinancialRichard Newitter	$134	8.9% upside
2024-06-20	Wolfe ResearchMike Polark	$115	6.6% downside

iRhythm Technologies (IRTC) FAQ

iRhythm Technologies posts a target price of $170. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $170 for IRTC means covering analysts, on average, see the stock 36.2% upside of $123.07 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for IRTC's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; iRhythm Technologies's other metric pages and overview cover the third.

Judging iRhythm Technologies against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $170 here, then scan peer and history charts to see if the gap is persistent.